Loading...
Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience
BACKGROUND: Anaemia is common in haemodialysis (HD) patients and associated with significant morbidity and mortality. Intravenous (IV) iron combined with erythropoiesis-stimulating agents (ESA) is the mainstay treatment of anaemia in these patients. The comparative efficacy and risk of adverse event...
Na minha lista:
| Udgivet i: | BMC Nephrol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7271492/ https://ncbi.nlm.nih.gov/pubmed/32493240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-01866-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|